1.
Sang Thrombose Vaisseaux
; 34(2):89-97, 2022.
Article
in French
| EMBASE | ID: covidwho-1917076
ABSTRACT
Heparins are made up of glycosaminoglycan chains that we do have known and used for decades for their anticoagulant properties mainly anti-Xa and anti-IIa. In recent years, apart from anticoagulant effects, attention was drawn to the pleiotropic effects of heparins. Some of these effects are potentially useful in the management of patients infected with Covid-19. Indeed in vitro studies reveal many potential side effects of heparins that could be useful in such viral infections, and clinical studies reinforce the interest and the effectiveness of heparin in patients infected with this virus.
2.
Nutrition Clinique et Metabolisme
; 36(1):S33, 2022.
Article
in French
| EMBASE | ID: covidwho-1734851
ABSTRACT
Déclaration de liens d’intérêts: Les auteurs déclarent ne pas avoir de liens d’intérêts.